手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按作者
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
313条
与
L.
有关的结果
The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature
2021 年 发布于
ANZ J Surg
7 卷 第 01 期
Ornaghi P. I.
Afferi
L.
Antonelli A.
Cerruto M. A.
Odorizzi K.
Gozzo A.
Mordasini
L.
Mattei A.
Baumeister P.
Cornelius J.
Tafuri A.
Moschini M.
荧光膀胱镜
普通白光膀胱镜
膀胱癌
诊断
Meta分析
文献简介
原文链接
The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials
2021 年 发布于
Arab Journal of Urology
108 卷 第 3 期
Li F.
Wang Y.
Xie K.
Fang Y.
Du Y.
Hou
L.
Tan W.
Humans
Lymphocytes/*pathology
Neutrophils/*pathology
*Preoperative Care
Prognosis
Publication Bias
Survival Analysis
Urinary Bladder Neoplasms/*immunology/*surgery
文献简介
原文链接
Safety and efficacy of bipolar versus monopolar transurethral resection of bladder tumor: a systematic review and meta-analysis
2021 年 发布于
World J Urol
39 卷 第 5 期
Zhou Z. B.
Gao Z.
L.
Wu J. T.
Cui Y. S.
Biomarkers
Tumor/*analysis
Carcinoma
Transitional Cell/*chemistry/*drug therapy
Humans
Neoadjuvant Therapy
Prognosis
Urinary Bladder Neoplasms/*chemistry/*drug therapy
Biomarkers
Nac
Neoadjuvant systemic therapy
Ucb
bladder cancer
systematic review
文献简介
原文链接
Reactive Arthritis following Bacillus Calmette-Guerin Therapy for Bladder Cancer: a Systematic Literature Review
2021 年 发布于
Am J Clin Nutr
11 卷 第 7-8 期
Ben Abdelghani K.
Nacef
L.
Miladi S.
Sellami M.
Ouenniche K.
Souabni
L.
Kassab S.
Chekili S.
Fazaa A.
Laatar A.
吡柔比星
丝裂霉素C
经尿道膀胱肿瘤切除术
升温灌注
荟萃分析
文献简介
原文链接
Methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) versus gemcitabine, and cisplatin (GC) as neoadjuvant chemotherapy in muscle-invasive bladder cancer, a systematic review and meta-analysis
2021 年 发布于
World Journal of Surgical Oncology
12 卷 第 10 期
Benkhadra R.
Nayfeh T.
Patibandla N. S. K.
Peterson C.
Prokop
L.
Alhalabi O.
Murad M. H.
Mao S. F.
高级别非肌层浸润性膀胱癌
根治性膀胱切除术
保留膀胱术
meta分析
临床疗效
文献简介
原文链接
Intravesical chemohyperthermia versus bacillus calmette-guerin instillation for intermediate- and high-risk non-muscle invasive bladder cancer: A systematic review and meta-analysis
2021 年 发布于
Photodiagnosis Photodyn Ther
127 卷 第 7 期
Zhao H.
Chan V. W.
Castellani D.
Chan E. O.
Ong W.
L.
K.
Peng Q.
Moschini M.
Krajewski W.
Pradere B.
Ng C.
Enikeev D.
Vasdev N.
Ekin G.
Sousa A.
Leon J.
Guerrero-Ramos F.
Tan W.
Kelly J.
Shariat S. F.
Witjes J.
Teoh J. Y.
Adjuvants
Immunologic/*administration & dosage
Administration
Intravesical
BCG Vaccine/*administration & dosage
Humans
*Lymphocytes
Tumor-Infiltrating
Treatment Outcome
Urinary Bladder Neoplasms/*drug therapy/immunology/*pathology
文献简介
原文链接
Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis
2021 年 发布于
现代泌尿外科杂志
30 卷 第 1 期
Cai Z. Y.
Jin H.
Chen J. B.
Hu J.
Li H. H.
Yi Z.
L.
Zu X. B.
Anti-Bacterial Agents/therapeutic use
Antibiotic Prophylaxis
Humans
Meta-Analysis as Topic
Postoperative Complications/drug therapy
Systematic Reviews as Topic
*Urinary Bladder Neoplasms/drug therapy/surgery
*Urinary Tract Infections/drug therapy/prevention & control
Antibiotic resistance
Antibiotics
Antimicrobial stewardship
Bacteriuria
Endourological surgery
Guideline
Recommendation
Transitional cell carcinoma
Urothelium cell carcinoma
文献简介
原文链接
Development of Sarcopenia in Patients With Bladder Cancer: A Systematic Review
2021 年 发布于
Eur Urol
44 卷 第 6 期
Hansen T. T. D.
Omland
L.
H.
von Heymann A.
Johansen C.
Clausen M. B.
Suetta C.
Pappot H.
Rafn B. S.
Aged
*Brachytherapy
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Male
Middle Aged
Neoplasm Recurrence
Local
*Urinary Bladder Neoplasms/mortality/pathology/radiotherapy
external beam radiotherapy
interstitial brachytherapy
muscle-invasive bladder cancer
organ preservation
文献简介
原文链接
Vaginal Complications after Radical Cystectomy for Bladder Cancer: A Systematic Review
2021 年 发布于
BMJ Open
39 卷 第 6 期
Richter
L.
A.
Egan J.
Alagha E. C.
Handa V.
L.
膀胱癌
根治性膀胱切除术
尿流改道术
生活质量
Meta分析
文献简介
原文链接
Short-term morbidity and mortality following radical cystectomy: a systematic review
2021 年 发布于
Journal of Urology
127 卷 第 2 期
Maibom S.
L.
Joensen U. N.
Poulsen A. M.
Kehlet H.
Brasso K.
Røder M. A.
Age of Onset
Cohort Studies
Female
Hormones/*metabolism
Humans
Menopause
Middle Aged
Parity
Prospective Studies
*Reproduction
Risk Assessment
Risk Factors
United States/epidemiology
Urinary Bladder Neoplasms/epidemiology/*physiopathology
Plco
bladder cancer
hormones
meta-analysis
reproductive factors
interest.
文献简介
原文链接
Comparison of survival outcomes between primary and secondary muscle-invasive bladder cancer: An updated meta-analysis
2021 年 发布于
J Robot Surg
15 卷 第 1 期
Zheng X. N.
Qiu S.
Yang
L.
Wei Q.
5-alpha Reductase Inhibitors/therapeutic use
Androgen Antagonists/therapeutic use
Androgens/therapeutic use
*Carcinoma in Situ
Humans
Male
*Prostatic Neoplasms/pathology
*Urinary Bladder Neoplasms/pathology
*Androgen suppression therapy
*Androgens
*Bladder cancer
*Incidence
*Recurrence
*Systematic review
文献简介
原文链接
Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications
2021 年 发布于
Urologic Oncology-Seminars and Original Investigations
12 卷 第 2 期
Seguier D.
Puech P.
Kool R.
Dernis
L.
Gabert H.
Kassouf W.
Villers A.
Marcq G.
Antineoplastic Agents
Alkylating/pharmacology/*therapeutic use
Cyclophosphamide/pharmacology/*therapeutic use
Female
Humans
Male
Survival Analysis
Urinary Bladder Neoplasms/*drug therapy/mortality
Cyclophosphamide
Hematuria
Systematic review
Urinary bladder neoplasms
文献简介
原文链接
Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer
2021 年 发布于
Nitric Oxide
39 卷 第 4 期
Veeratterapillay R.
Gravestock P.
Nambiar A.
Gupta A.
Aboumarzouk O.
Rai B.
Vale
L.
Heer R.
Humans
Incidence
Risk Factors
Suicide/*statistics & numerical data
Urinary Bladder Neoplasms/diagnosis/*psychology
Bladder cancer
Meta-analysis
Suicide
Systematic review
文献简介
原文链接
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
2021 年 发布于
PLoS One
49 卷 第 9 期
Crocetto F.
di Zazzo E.
Buonerba C.
Aveta A.
Pandolfo S. D.
Barone B.
Trama F.
Caputo V. F.
Scafuri
L.
Ferro M.
Cosimato V.
Fusco F.
Imbimbo C.
Di Lorenzo G.
Bayes Theorem
Cystectomy
Humans
Laparoscopy
Robotic Surgical Procedures
Urinary Bladder Neoplasms/*surgery
文献简介
原文链接
Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text
2021 年 发布于
Can Urol Assoc J
15 卷 第 8 期
Bhindi B.
Kool R.
Kulkarni G. S.
Siemens D. R.
Aprikian A. G.
Breau R. H.
Brimo F.
Fairey A.
French C.
Hanna N.
Izawa J. I.
Lacombe
L.
McPherson V.
Rendon R. A.
Shayegan B.
So A. I.
Zlotta A. R.
Black P. C.
Kassouf W.
Guidelines as Topic
Humans
Immunotherapy/*methods
Societies
Medical/*standards
Urinary Bladder Neoplasms/*drug therapy
antineoplastic protocols
immunotherapy
urinary bladder neoplasms
urologic neoplasms
Pfizer
AstraZeneca
Nektar
Seattle Genetics
DragonFly Therapeutics
Non-CME
services: Genentech
AstraZeneca
Merck
Seattle Genetics
Contracted research:
Genentech
Merck
AstraZeneca
Nektar
Seattle Genetics
Immunomedics.
PCB─Consulting fees: AbbVie
Asieris Pharmaceuticals
Astellas
AstraZeneca
Bayer
Biosyent
Bristol-Myers Squibb
EMD Serono
Ferring
Fergene
H3
Biomedicine
Janssen
Merck
Roche
Sanofi
TerSera
Urogen
Contracted research:
iProgen. MTC─Consulting fees: Pfizer
EMD Serono
AstraZeneca
Exelixis
Eisai
Seattle Genetics
Astellas
Contracted research: Exelixis
Pfizer/EMD Serono
Janssen
Apricity Health. GSD─Participant/unpaid volunteer: HealthVibe focus
group 2020. MDG─Consulting fees: Inovio
NuMab
Janssen
Merck
GlaxoSmithKline
Genentech
Bristol-Myers Squibb
Seattle Genetics
Dracen
Dragonfly
Astellas
Novartis
Pfizer
AstraZeneca
Incyte
Dendreon
Eli Lilly
EMD Serono
Aileron
Therapeutics
Ownership interest: Rappta Therapeutics
NPI: 1639140668.
PG─Consulting fees: AstraZeneca
Dyania Health
EMD Serono
Immunomedics
Janssen
Merck
Mirati Therapeutics
Genentech
Pfizer
Seattle Genetics
Contracted Research: Bavarian Nordic
Bristol-Myers Squibb
Clovis Oncology
Debiopharm
Immunomedics
Pfizer
Merck
QED Therapeutics
GlaxoSmithKline
Kure
It Cancer Research
Mirati Therapeutics. SG─Consulting fees: Merck
Bristol-Myers
Squibb
Janssen
Seattle Genetics
AstraZeneca
Contracted research:
Bristol-Myers Squibb
Pfizer
Non-CME services: Exelixis. CJH─Consulting fees:
Astellas
Bristol-Myers Squibb
Genentech
Merck
Eisai
Seattle Genetics
2bPrecise
Non-CME services: Astellas
Bristol-Myers Squibb
Genentech
Eisai
Seattle Genetics. AMK─Consulting fees: Abbott Molecular
Arquer
ArTara
Asieris
AstraZeneca
BioClin Therapeutics
Bristol-Myers Squibb
Cepheid
Cold Genesys
Eisai
Engene
Inc.
Ferring
FerGene
Imagin
Janssen
MDxHealth
Medac
Merck
Pfizer
Photocure
ProTara
Roviant
Seattle Genetics
Sessen Bio
Theralase
TMC
Innovation
US Biotest
Contracted research: Adolor
Bristol-Myers Squibb
FKD
Industries
Heat Biologics
Merck
Photocure
SWOG/NIH
SPORE
AIBCCR
Clinical
trials: FKD
Merck
Bristol-Myers Squibb
Photocure
SWOG
Adolor
Heat
Biologics
Laboratory research: NIH
SPORE
AIBCCR
Educational grant: CEC
Oncology
Editorial board: European Urology Oncology
Journal of Urology
UroToday
President of organization: International Bladder Cancer Network (IBCN)
International Bladder Cancer Group (IBCG)
IP Rights: CyPRIT (Cytokine Predictors
of Response to Intravesical Therapy) Joint with UT MD Anderson Cancer Center.
LPL─Consulting fees: Pfizer Advisory Nursing board
2018
Lecture/Speaker/Expert
Panel: ASCO Bladder Program 2019
Pfizer learning day 2019
ASCO Bladder Program
Panel Member and Faculty 2019
Pfizer Learning Day Speaker 2019
BCAN Webinar
Faculty 11/2020. JJM─Consulting fees: AstraZeneca
Ferring
Janssen
Nucleix
Foundation Medicine
Contracted research: Epizyme
Tesaro
Abbvie
Teaching an
endoscopy course: Olympus. ERP─Consulting fees: AstraZeneca
Infinity Pharma
Pfizer
Flatiron
Genentech
Merck
Seattle Genetics
Contracted research:
Astellas
Bristol-Myers Squibb
Genentech
Merck. JER─Consulting fees: Merck
Bristol-Myers Squibb
AstraZeneca
Astellas
Seattle Genetics
Boehringer
Ingelheim
Bayer
Pfizer
Roche/Genentech
Mirati
QED Therapeutics
Janssen
Pharmacyclics
GlaxoSmithKline
Contracted research/Clinical trial funding:
Seattle Genetics
Astellas
Roche/Genentech
Bayer
AstraZeneca
QED
Therapeutics. NS─Consulting fees: Amgen
Astellas
AstraZeneca
Bayer
Bristol-Myers Squibb
Dendreon
Fergene
Ferring
Janssen
Merck
Myovant
Nymox
Pfizer
Sanofi/Genzyme
Sesen Bio
Sun Pharma
Tolmar. GDS─Consulting fees:
Merck
Janssen
Ferring
Bristol-Myers Squibb
Pfizer
Genentech
Epivax
Oncology
AstraZeneca
Fidia
Cold Genesys
EnGene Bio
Aduro Biotech
Dendreon
FKD Therapies
CiClomed
Seattle Genetics
Urogen
PhotoCure. SITC staff:
SMW—Shares owned: Pacific Biosciences
Editas Medicine
EG
AK
BL
LL─Nothing to
disclose.
文献简介
原文链接
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
2021 年 发布于
J Immunother Cancer
9 卷 第 7 期
Galsky M. D.
Balar A. V.
Black P. C.
Campbell M. T.
Dykstra G. S.
Grivas P.
Gupta S.
Hoimes C. J.
Lopez
L.
P.
Meeks J. J.
Plimack E. R.
Rosenberg J. E.
Shore N.
Steinberg G. D.
Kamat A. M.
窄带成像
非肌层浸润性膀胱癌
经尿道膀胱肿瘤电切术
安全性
共识
文献简介
原文链接
ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update
2021 年 发布于
J Am Coll Radiol
18 卷 第 5s 期
Allen B. C.
Oto A.
Akin O.
Alexander
L.
F.
Froemming A. T.
Fulgham P. F.
Halpern D. J.
Gettle
L.
M.
Maranchie J. K.
Patel B. N.
Patlas M. N.
Schieda N.
Solanki A.
Turkbey I. B.
Venkatesan A. M.
Yoo D. C.
Lockhart M. E.
*Carcinoma
Transitional Cell
Evidence-Based Medicine
Humans
*Radiology
Societies
Medical
United States
*Urinary Bladder Neoplasms/diagnostic imaging
Auc
Appropriate Use Criteria
Appropriateness Criteria
Bladder cancer
Muscle invasive bladder cancer
Nonmuscle invasive bladder cancer
Surveillance
Transitional cell carcinoma
Urothelial cancer
文献简介
原文链接
Bladder volume reproducibility after water consumption in patients with prostate cancer undergoing radiotherapy: A systematic review and meta-analysis
2021 年 发布于
局解手术学杂志
99 卷 第 3 期
Chen H. H.
Lin P. T.
Kuo
L.
T.
Lin K. S.
Fang C. C.
Chi C. C.
Radical cystectomy
Vi-rads
muscle-invasive bladder cancer
urothelial carcinoma
文献简介
原文链接
The association between hepatitis C virus infection and renal cell cancer, prostate cancer, and bladder cancer: a systematic review and meta-analysis
2021 年 发布于
Translational Andrology and Urology
37 卷 第 5-6 期
Ma Y. C.
Huang Z.
L.
Jian Z. Y.
Wei X.
Cystectomy/adverse effects/*methods
Humans
Laser Therapy/adverse effects/*methods
Neoplasm Invasiveness
Treatment Outcome
Urethra
Urinary Bladder Neoplasms/pathology/*surgery
Bladder cancer
Laser surgery
Systematic review and meta-analysis
Transurethral resection
文献简介
原文链接
Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies
2021 年 发布于
Front Endocrinol (Lausanne)
12 卷 第 8 期
Creta M.
Celentano G.
Napolitano
L.
La Rocca R.
Capece M.
Califano G.
Collà Ruvolo C.
Mangiapia F.
Morra S.
Turco C.
Spirito
L.
Fusco F.
Imbimbo C.
Mirone V.
Longo N.
Vi-rads
bladder cancer
bladder cancer staging
inter-reader agreement
multiparametric magnetic resonance imaging
muscle-invasive bladder cancer
文献简介
原文链接
首页
上一页
1
2
...
5
6
7
8
9
10
11
...
15
16
下一页
尾页
共313条,每页显示
20条
50条
100条
跳转至第
页
确定